Valsartan Tablets USP 320 mg recalled over manufacturing violations
- Recall date
- August 15, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Preferred Pharmaceuticals, Inc recalls Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250…
- Recall number
- D-1107-2018
- FDA classification
- Class II
- Brand / firm
- Preferred Pharmaceuticals, Inc
- Sold / distributed
- Products were distributed to one distributor in Alabama who may have further distributed the product to the consumer level.
Why it was recalled
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9
Get recall alerts
Free email alert whenever Preferred Pharmaceuticals, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Preferred Pharmaceuticals, Inc